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therapeutics. We have attempted to deﬁne elements of a hemato-
poietic stem cell niche by focusing on the endosteal surface where
some stem cells are known to localize in the adult mammal. Using
genetic models altering features of the bone or the stem cell
response to bone elements, we and others have begun to charac-
terize components of the endosteal stem cell niche. The molecular
interactions governing the effects of the niche provide potential
targets for drug based therapies and some of these can simply
re-purpose existing compounds. Using PTH analogues developed
for osteoporosis for example has been shown to alter the outcome
of both stem cell harvesting and engraftment procedures in the
mouse model. The application of these models to human trials has
begun. Targeting the niche may modify the complex systems in
which stem cells reside and provides a distinct therapeutic ap-
proach to stem cell based medicine.
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MANAGEMENT OF PRIMARY GRAFT FAILURE AFTER UNRELATED UM-
BILICAL CORD BLOOD TRANSPLANTATION
Ka Wah Chan, Michael S. Grimley, Candace Taylor, Donna A. Wall
Division of Pediatric Stem Cell Transplantation, Texas Transplant
Institute and Methodist Children’s Hospital, San Antonio, Texas
Primary graft failure (GF) is a major risk in unrelated donor
umbilical cord blood transplant (UCBT). We retrospectively re-
viewed data from 100 consecutive patients transplanted at Texas
transplant Institute between 3/2001 and 8/2006, and analyzed the
risk factors and the management of this complication. Their me-
dian age was 5.3 (range 0.1-8.4) years, and median weight 22 (range
4-85) kg. Seventeen did not achieve myeloid recovery; deﬁned as
an absolute neutrophil count (ANC)  500/	l by day 28. Of these,
8 died early from transplant-related complications or persistent
leukemia. Nine patients received 2nd UCBT in 33 to 95 (median
55) days. Their diagnoses were: ALL (3), MDS (1), HLH (2), SAA
(1), CD40L deﬁciency (1). Intensive immunosuppression condi-
tioning was used: the commonest regimen being ﬂudarabine
175mg/m2, cyclophosphamide 50mg/kg, TBI 2 Gy, 
 ATG (6
patients). Median cell dose for 2nd UCBT was 7.8  107/kg.
Degree of HLA matching was similar to 1st UCBT. 8/9 evaluable
patients engrafted; ANC 500/	l at a median of 15 (range 5-64)
days, platelets  20,000 /	l at a median of 92 (range 24 to 137)
days after the 2nd UCBT. All achieved complete donor chimerism.
As of 2/28/2007, 5/9 patients are alive, 758-1,828 (median 1,224)
days after 2nd UCBT. EBV-lymphoproliferatve disorders devel-
oped in 2 patients. Late infections were common: viral infections
included: BKV(2), HHV-6(2), CMV (2); and adenovirus (1). These
were severe and protracted. Acute graft-versus-host disease
(GVHD) diagnosed in 3/ 8, and chronic GVHD in 6/8 patients.
Three patients remain on immunosuppressive therapy. Chimerism
study by PCR was predictive of subsequent engraftment: any result
showing  5% donor cells was associated with irreversible graft
loss. In conclusion, early 2nd UCBT is a feasible treatment for
primary GF. Using an immunosuppressive preparative regimen
lead to reliable engraftment, but the incidence of chronic GVHD
and viral reactivation were high.
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DIRECT INTRA BONE TRANSPLANT OF UNRELATED CORD BLOOD
CELLS IS ASSOCIATED WITH FAST AND COMPLETE HEMATOLOGIC
RECOVERY
A. Ibatici, A.M. Raiola, F. Gualandi, N. Sessarego, A. Parodi, S. Pozzi,
M. Gobbi, M. Corselli, M. Podesta`, G. Piaggio, A. Bacigalupo and F.
Frassoni Centro Cellule Staminali e Terapia Cellulare, Divisione Ema-
tologia, Clinica Ematologia, Ospedale San Martino, Genova, Italy
Background. Cord blood transplants (CBT) are associated with
delayed or failed engraftment in a signiﬁcant proportion of pa-
tients. Two of our previous observations suggested (i) that, in the
animal model, direct intra-bone (i.b.) injection of hematopoietic
cells improves seeding efﬁciency and (ii) that the delayed engraft-
ment was not related to an insufﬁcient number of hematopoietic
stem cells but rather to a reluctance to differentiation and matu-
ration. Methods. Unrelated CB (4/6 or 5/6 HLA antigen matched)
were selected for 20 consecutive patients. Median cell dose was
2.6  10∧7/kg (range 1.6-3.5). CB cells were concentrated in a
total volume of 20 ml and infused in the supero-posterior iliac crest
(SPIC) under rapid general anesthesia (10 minutes with propofol).
Patients median age was 38 years (18-63), 16 had acute leukemia,
2 chronic myeloid leukemia, 2 Hodgkin disease. Sixteen patients
had refractory or advanced disease, whereas 4 had high risk ﬁrst
remission leukemia. Most patients (n16) were prepared with
conventional CY-TBI. Results. The infusion of cells i.b. in supero-
posterior iliac rest (SPIC), in the operating room, under short
general anaesthesia, was uneventful. All patients engrafted. Cumu-
lative incidence of neutrophil and platelet engraftment was 100%
at 50 days. Median for neutrophil engraftment (0.510∧9/l) was
day 23 (14-40), whereas for platelets (2010∧9/l) it was day 38
(range 22-47). Three patients are not evaluable because they died
within day 10 from transplant. Two patients relapsed and two died
of infection and multiorgan failure. Twelve patients are alive and
well in hematologic remission at a median follow up of 6 months
(range 2-11). 100% donor chimerism was documented since 30
days onward after transplant, including those in which CB cells
were injected monolaterally in one SPIC. From day60, CFC and
LTC-IC had already reached the lower values of the range of
normal individuals in bilateral sites. This is particularly relevant
considering that hemopoietic progenitor reconstitution remains
deﬁcient years after allo-transplant. Thus, direct injection of CB
cells in the bone marrow spaces produces in situ proliferation and
maturation, rapid recovery of peripheral blood counts, and early
recirculation of stem cells to other un-injected bone marrow sites.
Acute GvHD grade II was seen in 2/20 patient (10%). Since
lymphocyte trafﬁcking is known to be an essential part of immune
response, two combined factors might contribute: (i) injected T
cells come immediately in direct contact with mesenchymal stem
cells (MSC) and osteoblasts which are known to be potent immu-
nomodulators; (ii) the T cells present in the graft do not reach
primarily in the lymphatic organs, where they would be immedi-
ately confronted with host antigen presenting cells, as it probably
occurs after intra-venous injection. Conclusion. This study shows
that CB cells injected directly into the iliac crests are associated
with fast and complete hematologic recovery and almost absent
acute GvHD. The direct intra-bone transplant of CB cells could
now be offered to many more adult patients. This may change our
policy of hemopoietic cell transplants.
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A “NO-WASH” ALBUMIN-DEXTRAN DILUTION STRATEGY FOR UMBIL-
ICAL CORD BLOOD (UCB) THAW FOR ADOLESCENT AND ADULT UCB
TRANSPLANT RECIPIENTS: SUPERIOR TO WASH?
Juliet N. Barker, Rebecca Hawke, Allison Schaible, Michelle Abboud,
Nancy H. Collins, and Andromachi Scaradavou
The albumin-dextran wash, appropriate for small children, has
been adopted for adult UCB transplant (UCBT) recipients as a
matter of convention. However, an alternative strategy dilutes the
product in albumin-dextran without centrifugation. This “no
wash” technique could be advantageous for adolescents and adults
in whom even small cell losses may be clinically signiﬁcant, and
who are likely to tolerate small amounts of DMSO. Further, unlike
a bedside thaw, albumin-dextran dilution is still conducted in the
controlled environment of the Cytotherapy Laboratory. There-
fore, we conducted a prospective study of albumin-dextran dilution
in clinical UCBT. UCBT recipients  40 kg were eligible. Our
hypothesis was that the “no wash” thaw will be comparable to wash
in terms of post-thaw TNC yield and engraftment. To date, 37
units have been thawed using albumin-dextran dilution and trans-
planted into 19 patients (all received double unit grafts 4-6/6 HLA
matched, one red cell containing unit was washed). All patients
(median age 36 years, range 10-65 years; median weight 77 kg,
range 49-111) had hematological malignancies. A 5:1 Gen-
tran®40/ 25% albumin solution was used. Red cell depleted units
(n 35) were thawed to a dilution 5.5 fold [median ﬁnal volume
200 mls (range 200-500mls)]. The larger volume red cell contain-
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